Online citations, reference lists, and bibliographies.
← Back to Search

Conservative Management Of 386 Cases Of Unilateral Vestibular Schwannoma: Tumor Growth And Consequences For Treatment.

W. E. Bakkouri, R. Kania, J. Guichard, G. Lot, P. Herman, P. T. Huy
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECT The object of this study was to evaluate the natural history, pattern, and occurrence of tumor growth and its consequences for treatment of small-sized vestibular schwannomas (VSs). METHODS From 1990 to 2005, 386 patients underwent conservative management for VS because of the following: age > 60 years, poor health/medical risks, risk of deterioration of good hearing, small tumor size, minimal or no incapacitating symptoms, and/or patient preference. Tumor size was measured by MR imaging according to the guidelines of the Committee on Hearing and Equilibrium. The first MR imaging study was performed 1 year after diagnosis, and subsequent imaging was performed yearly or every 2 years depending on the appearance of new symptoms, tumor growth, or both. RESULTS Sixty-one patients were lost to follow-up the first year after presentation. Of the 325 patients for whom 1-year follow-up data were available, 39 showed tumor growth > or = 3 mm. Conservative management was discontinued for these 39 patients. The patients who returned for follow-up were evaluated at 1- or 2-year intervals depending on tumor growth. The authors extrapolated to obtain data for 2-year intervals, yielding data for 160, 56, 21, and 8 patients at 3, 5, 7, and 9 years after initial presentation, respectively. The overall mean tumor growth rate (+/-standard deviation) was 1.15 +/- 2.4 mm/year. This rate was estimated by pooling all values of tumor growth that had been determined for all patients and dividing by the total number of "events," with each assessment constituting an event. In 58.6% of patients, the annual tumor growth rate was < 1 mm/year; in 29.2%, 1-3 mm/year; and in 12.2%, > or = 3 mm/ year. The growth rates of intrameatal (1.02 +/- 1.8 mm/year) and extrameatal (1.40 +/- 3.1 mm/year) tumors did not differ significantly. No significant association was found between tumor growth rate and sex, age, initial hearing status, or initial tumor grade. Delay in diagnosis was the only significant factor associated with tumor growth rate. During follow-up, conservative management was discontinued for 77 (23.7%) of the 325 patients for whom at least 12-month follow-up data were available; surgery was performed in 60 (77.9%) and radiation therapy in 17 (22.1%). CONCLUSIONS The results of this study support the role of a conservative "wait-and-scan" policy of management for small-sized VSs because most have a slow growth rate. Long-term neuroimaging follow-up is needed even with non-growing tumors.
This paper references
10.3171/JNS.2006.105.2.205
Surgery for large vestibular schwannomas: how patients and surgeons perceive quality of life.
K. Nicoucar (2006)
10.1080/00016489850183395
Acoustic neuroma/vestibular schwannoma growth: past, present and future.
S. Charabi (1998)
10.1097/00129492-200307000-00019
New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma.
J. Kanzaki (2003)
10.1080/000164800750046027
Middle Fossa Approach in Vestibular Schwannoma Surgery. Postoperative Hearing Preservation and EEG Changes
J. Thomsen (2000)
10.1002/cncr.21190
Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma
S. H. Paek (2005)
Middle fossa approach for hearing preservation with acoustic neuromas.
W. Slattery (1997)
10.1177/019459989010300106
Retrosigmoid Removal of Acoustic Neuroma: Experience 1978–1988
S. Harner (1990)
10.1097/00005537-200503000-00011
Conservative Management of Acoustic Neuroma: A Meta‐Analysis and Proposed Treatment Algorithm
E. Smouha (2005)
Hearing restoration in posterior fossa tumors.
Y. J. Shin (1998)
10.1111/J.1365-2273.2004.00881.X
Quality of life following microsurgery, radiosurgery and conservative management for unilateral vestibular schwannoma.
D. Sandooram (2004)
Conservative management of unilateral acoustic neuromas.
D. Tschudi (2000)
10.1097/01.mlg.0000154736.38904.c3
Unilateral Acoustic Neuromas: Long‐Term Hearing Results in Patients Managed with Fractionated Stereotactic Radiotherapy, Hearing Preservation Surgery, and Expectantly
Vincent Y. W. Lin (2005)
10.1016/j.otohns.2004.02.006
Patient Choice in Treatment of Vestibular Schwannoma
M. Pogodzinski (2004)
10.1097/00129492-200305000-00017
Is It Worthwhile to Attempt Hearing Preservation in Larger Acoustic Neuromas?
Philip D Yates (2003)
10.1097/00129492-200207000-00025
Predicting the Stability and Growth of Acoustic Neuromas
M. Beenstock (2002)
10.1080/02688690500305399
Vestibular schwannoma management: What is the ‘best’ option?
S. Rutherford (2005)
10.1016/S0194-5998(95)70138-9
Acoustic neuroma (vestibular schwannoma): growth and surgical and nonsurgical consequences of the wait-and-see policy.
S. Charabi (1995)
10.1016/J.IJROBP.2005.01.055
Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
S. Combs (2005)
10.1097/00005537-200004000-00002
MOSHER AWARD HONORABLE MENTION
S. Rosenberg (2000)
10.1097/00006123-199608000-00005
Conservative management of acoustic neuroma: an outcome study.
H. G. Deen (1996)
Effectiveness of conservative management of acoustic neuromas.
Y. J. Shin (2000)
10.1111/J.1365-2273.2004.00852.X
Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.
V. Raut (2004)
10.1007/s004050100369
Vestibular schwannoma: negative growth and audiovestibular features
E. M. Stipkovits (2001)
10.1097/00129492-200307000-00023
Acoustic Neuroma Surgery: The Results of Long-term Hearing Preservation
G. Chee (2003)
10.1016/S0385-8146(01)00078-5
Hearing loss and growth rate of acoustic neuromas in follow-up observation policy.
T. Sakamoto (2001)
10.1016/s0030-6665(20)30969-5
Conservative management of acoustic neuromas.
J. Nedzelski (1992)
Hearing preservation in conservation surgery for vestibular schwannoma.
F. Holsinger (2000)
10.3109/00016488809124991
Acoustic neuromas. Diagnostic delay, growth rate and possible non-surgical treatment.
J. Thomsen (1988)
10.1177/000348948809700110
Hearing Preservation in Unilateral Acoustic Neuroma Surgery
G. Gardner (1988)
10.1081/0036554021000028084
Neurotological Complications After Radiosurgery Versus Conservative Management in Acoustic Neuromas: A Systematic Review-based Study
Y. J. Shin (2003)
10.3171/JNS.2001.94.2.0211
Patient-assessed outcomes after excision of acoustic neuroma: postoperative symptoms and quality of life.
H. C. Martin (2001)
10.1288/00005537-199508000-00005
Conservative management of patients with small acoustic tumors
R. Wiet (1995)
10.1007/s00405-004-0771-7
Management of acoustic neuroma in the only hearing ear
Maged B. Naguib (2004)
10.1177/000348940611500107
Preoperative Predictive Factors for Hearing Preservation in Vestibular Schwannoma Surgery
Rohit (2006)
10.1080/0036554021000028075
Hearing Deterioration in Patients with a Non-growing Vestibular Schwannoma
K. Graamans (2003)
10.1007/s002340050475
The size of acoustic neuromas: CT and MRI
B. Fiirgaard (1997)
10.1016/S0360-3016(99)00079-6
Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma.
H. Shirato (1999)
10.1097/00129492-200501000-00015
Size and Growth Rate of Sporadic Vestibular Schwannoma: Predictive Value of Information Available at Presentation
Amit Herwadker (2005)
10.3171/jns.2005.102.s_supplement.0195
Radiosurgery of vestibular schwannomas: summary of experience in 829 cases.
L. Lunsford (2005)
10.1097/00005537-200002010-00012
Consequences to Hearing During the Conservative Management of Vestibular Schwannomas
R. Walsh (2000)
10.1288/00005537-199409000-00011
The natural history of untreated acoustic neuromas
B. Strasnick (1994)
10.1016/S0360-3016(03)00444-9
Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.
O. Meijer (2003)
10.1046/J.1365-2273.2000.00317.X
The role of conservative management of vestibular schwannomas.
R. Walsh (2000)
10.1097/01.mao.0000217356.73463.e7
The Natural History of Vestibular Schwannoma
Sven-Eric Stangerup (2006)
10.1055/S-2000-9510
Hearing preservation after acoustic neuroma surgery.
V. J. Jaisinghani (2000)
10.1080/00016480510038013
Conservative Management Versus Surgery for Small Vestibular SchwannomasGrayeli AB, Kalamarides M, Ferrary E, et al (Hôpital Beaujon, Clichy, France; Université Paris; Alexandria School of Medicine, Egypt) Acta Otolaryngol (Stockh) 125:1063–1068, 2005§
M. Paparella (2006)
10.1258/0022215054273089
Conservative management of sporadic unilateral acoustic neuromas.
D. Flint (2005)
10.1056/NEJM199811123392003
Long-term outcomes after radiosurgery for acoustic neuromas.
D. Kondziolka (1998)
10.3171/JNS.2005.102.1.0010
Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow up.
T. Hasegawa (2005)
10.1288/00005537-198902000-00010
Acoustic neuroma—the patient's perspective: Subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients
D. Wiegand (1989)
The growth of acoustic neuromas in volumetric radiologic assessment.
K. Niemczyk (1999)
10.1046/J.1365-2273.2003.00670.X
Is clinical growth index a reliable predictor of tumour growth in vestibular schwannomas?
A. Mohyuddin (2003)
10.1288/00005537-199210000-00010
Preservation of hearing and facial nerve function in resection of acoustic neuroma
J. Nadol (1992)
10.1097/00005537-200010000-00030
Vestibular Schwannoma Growth: The Continuing Controversy
S. Charabi (2000)
10.1097/01.MLG.0000217528.37106.2D
Sublocalization and Volumetric Growth Pattern of Intracanalicular Vestibular Schwannomas
P. Cayé-Thomasen (2006)



This paper is referenced by
10.5152/iao.2018.5360
EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined?
Romain E. Kania (2018)
Nasal septal deformities in chronic rhinosinusitis patients: clinical and radiological aspects Vestibology Vestibular assessment in patients with vestibular schwannomas: what really matters? Otology Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outc
Chirurgia Cervico-Facciale (2014)
10.1002/lary.21799
Contemporary management of acoustic neuromas
P. Theodosopoulos (2011)
Vestibular Function in Vestibular Schwannoma
Isaac Tranter-Entwistle (2016)
10.3174/ajnr.A5144
Pretreatment ADC Values Predict Response to Radiosurgery in Vestibular Schwannomas
A. Camargo (2017)
10.3171/2012.6.FOCUS12209
The approach to the patient with incidentally diagnosed vestibular schwannoma.
M. Hoa (2012)
10.1080/21695717.2017.1385333
Hearing preservation and growth of small vestibular schwannomas: preliminary outcomes from patients under observation
D. Cazzador (2017)
10.3171/2018.11.SPINE181168
Subtotal resection of cervical schwannomas and growth rate of residual tumors.
Sung Mo Ryu (2019)
10.1093/neuros/nyx568
Decision Making in the Wait-and-Scan Approach for Vestibular Schwannomas: Is There a Price to Pay in Terms of Hearing, Facial Nerve, and Overall Outcomes?
Sampath Chandra Prasad (2018)
Potentielle Merkmale für Dedifferenzierung und Tumorprogress in peripheren Nervenscheidentumoren
Michael Glatzel (2011)
Growth dynamics of the vestibular schwannoma
Jobin K. Varughese (2012)
10.1080/00016489.2020.1717608
MRI monitoring of small and medium-sized vestibular schwannomas: predictors of growth
M. Fieux (2020)
10.1016/j.jocn.2016.05.003
Growth rate of vestibular schwannoma
I. Paldor (2016)
10.1055/S-0043-119528
Modern Techniques of Radiation Therapy in the Treatment of Brain Tumors and Tumors of the Skull Base
Christian Diehl (2018)
10.1016/j.neurol.2011.07.009
Mathematical modeling of glioma on MRI.
Emmanuel Mandonnet (2011)
10.3171/2014.6.JNS132471
Retrosigmoid removal of small acoustic neuroma: curative tumor removal with preservation of function.
I. Yamakami (2014)
10.1016/j.otc.2012.01.001
The art of management decision making: from intuition to evidence-based medicine.
S. Sheth (2012)
10.1016/j.prro.2016.10.016
Radiotherapeutic management of vestibular schwannomas using size- and location-adapted fractionation regimens to maximize the therapeutic ratio.
Benjamin Slane (2017)
10.1080/01616412.2017.1390184
Quality of life in patients with unilateral vestibular schwannoma on wait and see – strategy
P C Klersy (2018)
10.1017/S0022215119000963
Screening for vestibular schwannoma in the context of an ageing population.
Supriyo Basu (2019)
10.1016/j.wneu.2015.02.005
Growth of Primary and Remnant Vestibular Schwannomas: A Three-Year Follow-Up Study.
Y. Tomita (2015)
10.1227/NEU.0b013e3182752b05
Contemporary Surgical Management of Vestibular Schwannomas: Analysis of Complications and Lessons Learned Over the Past Decade
Yoichi Nonaka (2013)
10.3171/2012.7.JNS10672
Longitudinal analysis of hearing before and after radiosurgery for vestibular schwannoma.
S. Yomo (2012)
10.1007/s40136-014-0064-7
Active Treatment is Not Indicated in the Majority of Patients Diagnosed with a Vestibular Schwannoma: A Review on the Natural History of Hearing and Tumor Growth
M. Møller (2014)
10.1016/j.wneu.2017.07.051
Prognostic Factors of Hearing Outcome in Untreated Vestibular Schwannomas: Implication of Subdivision of Their Growth by Volumetric Analysis.
Jin-Deok Joo (2017)
10.3171/2019.5.JNS1923
Volumetric growth rates of untreated vestibular schwannomas.
Zane Schnurman (2019)
10.1016/j.jocn.2018.12.022
Tumour stem cells in schwannoma: A review
Samuel W. Cutfield (2019)
10.1007/s00701-013-1924-5
Long-term quality of life and tumour control following gamma knife radiosurgery for vestibular schwannoma
T. Wangerid (2013)
10.14639/0392-100X-suppl.1-39-2019
Surgery of the lateral skull base: a 50-year endeavour
E. Zanoletti (2019)
10.1007/s00701-011-1213-0
Advantages of intra-capsular micro-enucleation of schwannoma arising from extremities
R. Date (2011)
10.1097/MAO.0b013e318241c086
Conservative Management Versus Stereotactic Radiation for Vestibular Schwannomas: A Meta-Analysis of Patients With More Than 5 Years’ Follow-Up
A. Maniakas (2012)
10.1007/978-3-319-99298-3_1
Acoustic Neuromas: General Considerations
I. Doğan (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar